Protein-bound uremic toxins. . .New targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease

Journal of Renal Nutrition

Volumn 23, Issue 6, 2013, Pages 464-466

  Soulage, Christophe O ^a   Koppe, Laetitia ^a,b   Fouque, Denis ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

4 CRESOL SULFATE; 4-CRESOL SULFATE; CRESOL; PREBIOTIC AGENT; SULFATE;

ANIMAL; ARTICLE; CHRONIC KIDNEY FAILURE; HUMAN; INSULIN RESISTANCE; INTESTINE; METABOLIC DISORDER; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CRESOLS; HUMANS; INSULIN RESISTANCE; INTESTINES; METABOLIC DISEASES; MICE; MICROBIOTA; PREBIOTICS; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; SULFURIC ACID ESTERS;

EID: 84886286929     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2013.06.003     Document Type: Article

References (22)

1. Shinohara K., Shoji T., Emoto M., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002, 13:1894-1900.
2. DeFronzo R.A., Alvestrand A., Smith D., et al. Insulin resistance in uremia. J Clin Invest 1981, 67:563-568.
3. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006, 7:85-96.
4. Friedman J.E., Dohm G.L., Elton C.W., et al. Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol 1991, 261:E87-E94.
5. Cecchin F., Ittoop O., Sinha M.K., et al. Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats. Am J Physiol 1988, 254:E394-E401.
6. Bailey J.L., Zheng B., Hu Z., et al. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 2006, 17:1388-1394.
7. Thomas S.S., Dong Y., Zhang L., et al. Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Kidney Int 2013, [In press].
8. Liao M.-T., Sung C.-C., Hung K.-C., et al. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol 2012, 2012:691369.
9. McCaleb M.L., Mevorach R., Freeman R.B., et al. Induction of insulin resistance in normal adipose tissue by uremic human serum. Kidney Int 1984, 25:416-421.
10. McCaleb M.L., Izzo M.S., Lockwood D.H. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 1985, 75:391-396.
11. Koppe L., Pillon N.J., Vella R.E., et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol 2013, 24:88-99.
12. Chow J. Probiotics and prebiotics: a brief overview. J Ren Nutr 2002, 12:76-86.
13. Meijers B.K.I., De Preter V., Verbeke K., et al. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 2010, 25:219-224.
14. De Preter V., Vanhoutte T., Huys G., et al. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 2007, 292:G358-G368.
15. Nakabayashi I., Nakamura M., Kawakami K., et al. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant 2011, 26:1094-1098.
16. Rossi M., Klein K., Johnson D.W., et al. Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis. Int J Nephrol 2012, 2012:673631.
17. Miyazaki T., Aoyama I., Ise M., et al. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant 2000, 15:1773-1781.
18. Namikoshi T., Tomita N., Satoh M., et al. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy. Hypertens Res 2009, 32:194-200.
19. Niwa T., Emoto Y., Maeda K., et al. Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients. Nephrol Dial Transplant 1991, 6:105-109.
20. Niwa T., Nomura T., Sugiyama S., et al. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int Suppl 1997, 62:S23-S28.
21. Kikuchi K., Itoh Y., Tateoka R., et al. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:2997-3002.
22. Goto S., Yoshiya K., Kita T., et al. Uremic toxins and oral adsorbents. Ther Apher Dial 2011, 15:132-134.